Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:HUGE

FSD Pharma (HUGE) Stock Price, News & Analysis

FSD Pharma logo

About FSD Pharma Stock (NASDAQ:HUGE)

Key Stats

Today's Range
$0.09
$0.10
50-Day Range
$0.08
$0.20
52-Week Range
$0.07
$1.68
Volume
22.33 million shs
Average Volume
10.14 million shs
Market Capitalization
$3.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.

Receive HUGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter.

HUGE Stock News Headlines

Buffett Dumps $982 Million in BofA Stock—What Does He Know?
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.
Why Elon Musk’s Robotaxi Dreams Are Premature
See More Headlines

HUGE Stock Analysis - Frequently Asked Questions

FSD Pharma Inc. (NASDAQ:HUGE) released its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.11.

Based on aggregate information from My MarketBeat watchlists, some other companies that FSD Pharma investors own include Meta Platforms (META), SNDL (SNDL), AMC Entertainment (AMC), Ford Motor (F), NVIDIA (NVDA), Fiverr International (FVRR) and NIO (NIO).

Company Calendar

Last Earnings
11/14/2023
Today
11/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
NASDAQ:HUGE
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

Net Income
$-17,900,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.33 per share

Miscellaneous

Free Float
36,695,000
Market Cap
$3.61 million
Optionable
Optionable
Beta
0.60
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:HUGE) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners